Dongzheng Gai

Changzhi, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Acute leukemia during pregnancy: a single center experience with 23 cases, 2012-2022 and literature review.

Acute leukemia during pregnancy: a single center experience with 23 cases, 2012-2022 and literature review.

Journal: Annals of medicine
Published: February 18, 2026

Pulmonary adverse events associated with monoclonal antibodies approved for multiple myeloma: a pharmacovigilance study based on the FDA adverse event reporting system.

Pulmonary adverse events associated with monoclonal antibodies approved for multiple myeloma: a pharmacovigilance study based on the FDA adverse event reporting system.

Journal: Expert opinion on drug safety
Published: April 30, 2025

Cystatin M/E Ameliorates Multiple Myeloma-Induced Hyper Osteolytic Bone Resorption.

Cystatin M/E Ameliorates Multiple Myeloma-Induced Hyper Osteolytic Bone Resorption.

Journal: Cancers
Published: January 19, 2025

Cystatin M/E ameliorates bone resorption through increasing osteoclastic cell estrogen influx.

Cystatin M/E ameliorates bone resorption through increasing osteoclastic cell estrogen influx.

Journal: Research square
Published: May 20, 2024

Identification and study of cuproptosis-related genes in prognostic model of multiple myeloma.

Identification and study of cuproptosis-related genes in prognostic model of multiple myeloma.

Journal: Hematology (Amsterdam, Netherlands)
Published: August 23, 2023

Endoplasmic reticulum stress-related signature predicts prognosis and immune infiltration analysis in acute myeloid leukemia.

Endoplasmic reticulum stress-related signature predicts prognosis and immune infiltration analysis in acute myeloid leukemia.

Journal: Hematology (Amsterdam, Netherlands)
Published: August 17, 2023

Bispecific BCMA/CD24 CAR-T cells control multiple myeloma growth.

Bispecific BCMA/CD24 CAR-T cells control multiple myeloma growth.

Journal: Nature communications
Published: July 11, 2023

A gene signature can predict risk of MGUS progressing to multiple myeloma.

A gene signature can predict risk of MGUS progressing to multiple myeloma.

Journal: Journal of hematology & oncology
Published: May 23, 2023

High NEK2 expression in myeloid progenitors suppresses T cell immunity in multiple myeloma.

High NEK2 expression in myeloid progenitors suppresses T cell immunity in multiple myeloma.

Journal: Cell reports. Medicine
Published: April 17, 2023

BCMA- and CST6-specific CAR T cells lyse multiple myeloma cells and suppress murine osteolytic lesions.

BCMA- and CST6-specific CAR T cells lyse multiple myeloma cells and suppress murine osteolytic lesions.

Journal: The Journal of clinical investigation
Published: April 11, 2023

CST6 suppresses osteolytic bone disease in multiple myeloma by blocking osteoclast differentiation.

CST6 suppresses osteolytic bone disease in multiple myeloma by blocking osteoclast differentiation.

Journal: The Journal of clinical investigation
Published: February 21, 2022

TRIP13 modulates protein deubiquitination and accelerates tumor development and progression of B cell malignancies.

TRIP13 modulates protein deubiquitination and accelerates tumor development and progression of B cell malignancies.

Journal: The Journal of clinical investigation
Published: December 15, 2020
Showing 1-12 of 14

Last Updated: 09/26/2026